---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-083220"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2024-07-12T23:59:59+00:00"
generated_at: "2026-05-31T20:59:44.533856+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals replaces auditor KMJ Corbin with Crowe LLP; no disagreements reported

## Summary
- Audit committee dismissed KMJ Corbin and appointed Crowe LLP on July 10, 2024, after KMJ partners joined Crowe.
- KMJ's reports for fiscal years 2022 and 2023 contained no adverse opinion but included a going concern explanatory paragraph.
- No disagreements or reportable events occurred during the two most recent fiscal years and subsequent interim period.
- KMJ provided a letter agreeing with the company's statements, filed as Exhibit 16.1.

## SEC filing metadata
- accession: 0000950170-24-083220
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2024-07-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/0000950170-24-083220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/eldn-20240710.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-083220
- JSON: https://secwatch.observer/filing/0000950170-24-083220.json
- Plain text: https://secwatch.observer/filing/0000950170-24-083220.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.